BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33416112)

  • 1. Astragaloside IV attenuates cerebral ischemia‑reperfusion injury in rats through the inhibition of calcium‑sensing receptor‑mediated apoptosis.
    Du SJ; Zhang Y; Zhao YM; Dong YJ; Tang JL; Zhou XH; Gao WJ
    Int J Mol Med; 2021 Jan; 47(1):302-314. PubMed ID: 33416112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Astragaloside IV against Cerebral Ischemia/Reperfusion Injury: Suppression of Apoptosis via Promotion of P62-LC3-Autophagy.
    Zhang Y; Zhang Y; Jin XF; Zhou XH; Dong XH; Yu WT; Gao WJ
    Molecules; 2019 May; 24(9):. PubMed ID: 31086091
    [No Abstract]   [Full Text] [Related]  

  • 3. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2.
    Xiao L; Dai Z; Tang W; Liu C; Tang B
    Oxid Med Cell Longev; 2021; 2021():9925561. PubMed ID: 35003524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways.
    Yin B; Hou XW; Lu ML
    Acta Pharmacol Sin; 2019 May; 40(5):599-607. PubMed ID: 30030530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway.
    Xu Z; Liu W; Huang H
    Pharmacology; 2020; 105(3-4):181-189. PubMed ID: 31825924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway.
    Yin F; Zhou H; Fang Y; Li C; He Y; Yu L; Wan H; Yang J
    J Ethnopharmacol; 2020 Feb; 248():112319. PubMed ID: 31639488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
    Wang L; Liu C; Wang L; Tang B
    Eur J Pharmacol; 2023 Apr; 944():175516. PubMed ID: 36758783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calycosin alleviates cerebral ischemia/reperfusion injury by repressing autophagy via STAT3/FOXO3a signaling pathway.
    Xu S; Huang P; Yang J; Du H; Wan H; He Y
    Phytomedicine; 2023 Jul; 115():154845. PubMed ID: 37148714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asiaticoside Alleviates Cerebral Ischemia-Reperfusion Injury via NOD2/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Zhang C; Chen S; Zhang Z; Xu H; Zhang W; Xu D; Lin B; Mei Y
    Med Sci Monit; 2020 Feb; 26():e920325. PubMed ID: 32006420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iridoid glycosides from Radix Scrophulariae attenuates focal cerebral ischemia‑reperfusion injury via inhibiting endoplasmic reticulum stress‑mediated neuronal apoptosis in rats.
    Chen Y; Zhang L; Gong X; Gong H; Cheng R; Qiu F; Zhong X; Huang Z
    Mol Med Rep; 2020 Jan; 21(1):131-140. PubMed ID: 31746404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of astragaloside IV regulating NLRP3 through LOC102555978 to attenuate cerebral ischemia reperfusion induced microglia pyroptosis.
    Gao P; Shi H; Jin X; Guo S; Zhou X; Gao W
    Int Immunopharmacol; 2024 Apr; 131():111862. PubMed ID: 38513574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geraniol-Mediated Suppression of Endoplasmic Reticulum Stress Protects against Cerebral Ischemia-Reperfusion Injury via the PERK-ATF4-CHOP Pathway.
    Wu Y; Fan X; Chen S; Deng L; Jiang L; Yang S; Dong Z
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats.
    Li L; Gan H; Jin H; Fang Y; Yang Y; Zhang J; Hu X; Chu L
    Int Immunopharmacol; 2021 Mar; 92():107335. PubMed ID: 33429332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia-reperfusion injury.
    Chen X; Yang T; Zhou Y; Mei Z; Zhang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14725. PubMed ID: 38615367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin-A alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress-mediated apoptosis.
    Xu D; Kong T; Cheng B; Zhang R; Yang C; Chen J; Wang C
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4'-O-methylbavachalcone alleviates ischemic stroke injury by inhibiting parthanatos and promoting SIRT3.
    Chen HQ; Zhang QG; Zhang XY; Zeng XB; Xu JW; Ling S
    Eur J Pharmacol; 2024 Jun; 972():176557. PubMed ID: 38574839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CEBPA-AS1 alleviates cerebral ischemia-reperfusion injury by sponging miR-340-5p regulating APPL1/LKB1/AMPK pathway.
    Tu X; Zhang H; Chen S; Ding YH; Wu X; Liang R; Shi SS
    FASEB J; 2022 Jan; 36(1):e22075. PubMed ID: 34919285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats.
    Shen F; Meng Y; He Y; Huang B; Huang J; Wang L
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36331022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin alleviates endoplasmic reticulum stress induced by cerebral ischemia/reperfusion injury via the PI3K/Akt signaling pathway.
    Zhang Y; Cheng D; Jie C; Liu T; Huang S; Hu S
    Biosci Rep; 2022 Dec; 42(12):. PubMed ID: 36367210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-
    Leng B; Zhang Y; Liu X; Zhang Z; Liu Y; Wang H; Lu M
    Mediators Inflamm; 2019; 2019():1082497. PubMed ID: 30906223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.